BVNKF Bavarian Nordic A/S

USD 26.59 0.00 0
Icon

Bavarian Nordic A/S (BVNKF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 26.59

0.00 (0.00)%

USD 2.11B

N/A

N/A

N/A

Icon

BVNKF

Bavarian Nordic A/S (USD)
COMMON STOCK | OTC
USD 26.59
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.11B

N/A

USD 26.59

Bavarian Nordic A/S (BVNKF) Stock Forecast

N/A

Based on the Bavarian Nordic A/S stock forecast from 0 analysts, the average analyst target price for Bavarian Nordic A/S is not available over the next 12 months. Bavarian Nordic A/S’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bavarian Nordic A/S is Bullish , which is based on 9 positive signals and 2 negative signals. At the last closing, Bavarian Nordic A/S’s stock price was USD 26.59. Bavarian Nordic A/S’s stock price has changed by +15.21% over the past week, +7.78% over the past month and -2.03% over the last year.

No recent analyst target price found for Bavarian Nordic A/S
No recent average analyst rating found for Bavarian Nordic A/S

Company Overview Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encepha...Read More

Philip Heymans Alle 3, Hellerup, Denmark, 2900

1,381

December

USD

USA

Adjusted Closing Price for Bavarian Nordic A/S (BVNKF)

Loading...

Unadjusted Closing Price for Bavarian Nordic A/S (BVNKF)

Loading...

Share Trading Volume for Bavarian Nordic A/S Shares

Loading...

Compare Performance of Bavarian Nordic A/S Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BVNKF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bavarian Nordic A/S (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S +1.50 (+1.14%) USD591.68B 45.03 4.92

ETFs Containing BVNKF

Symbol Name BVNKF's Weight Expense Ratio Price(Change) Market Cap
ETLI:F
Legal & General UCITS ETF.. 2.69 % 0.49 % +0.04 (+0.40%) USD0.02B

Frequently Asked Questions About Bavarian Nordic A/S (BVNKF) Stock

Stock Target Advisor's fundamental analysis for Bavarian Nordic A/S's stock is Bullish .

Unfortunately we do not have enough data on BVNKF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BVNKF's stock to indicate what its average analyst target is.

BVNKF stock's Price/Earning ratio is 14.37. Our analysis grades BVNKF stock's Price / Earning ratio at F. This means that BVNKF stock's Price/Earning ratio is above 48% of the stocks in the Biotechnology sector in the OTC exchange. Based on this BVNKF may be fairly valued for its sector

The last closing price of BVNKF's stock was USD 26.59.

The most recent market capitalization for BVNKF is USD 2.11B.

Unfortunately we do not have enough analyst data on BVNKF's stock to indicate whether its price will go up or not.

Following are ETFs with the highest allocation to Bavarian Nordic A/S's stock :

ETLI:F

As per our most recent records Bavarian Nordic A/S has 1,381 Employees.

Bavarian Nordic A/S's registered address is Philip Heymans Alle 3, Hellerup, Denmark, 2900. You can get more information about it from Bavarian Nordic A/S's website at https://www.bavarian-nordic.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...